Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Di Grandi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|June 21, 2014
Nazarov-like cyclization reactionsMartin J Di Grandi
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Thiourea inhibitors of herpesviruses. Part 3: Inhibitors of varicella zoster virusMartin J Di Grandi, Kevin J Curran, Gregg Feigelson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox propertiesMartin J Di Grandi, Kevin J Curran, Ellen Z Baum, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Novel pyrazolopyrimidines as highly potent B-Raf inhibitorsMartin J Di Grandi, Dan M Berger, Darrin W Hopper, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|June 21, 2014
Nazarov-like cyclization reactionsMartin J Di Grandi
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Thiourea inhibitors of herpesviruses. Part 3: Inhibitors of varicella zoster virusMartin J Di Grandi, Kevin J Curran, Gregg Feigelson, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox propertiesMartin J Di Grandi, Kevin J Curran, Ellen Z Baum, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Novel pyrazolopyrimidines as highly potent B-Raf inhibitorsMartin J Di Grandi, Dan M Berger, Darrin W Hopper, et al.
Pageof 1